Lacosamide
Lacosamide (INN, formerly known as erlosamide) is a medication developed by UCB for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain marketed under the trade name Vimpat.
Posted by admin / Under Lacosamide
Clinical Care Options Neurology- No Evidence of Congenital Abnormalities Following First-Trimester Prenatal Exposure to Lacosamide
Published on Thursday 29th of July 2010 08:44:41 AM
Posted by admin / Under Lacosamide
Clinical Care Options Neurology- Rapid Initiation of Adjuvant Lacosamide Feasible in Patients With Partial-Onset Seizures
Published on Thursday 29th of July 2010 08:44:41 AM
Posted by admin / Under Lacosamide
A sampling of consumer generated mentions with sentiment about the product, associated keywords like Keppra and Lacosamide and Zonegran, and source information. The article allows for a download of the case study excerpt and brief presentation on the beta software that made it possible.
Published on Thursday 29th of July 2010 08:44:41 AM
Posted by admin / Under Lacosamide
Back in October the FDA approved a new treatment for epilepsy. But how does it work and what are the risks?
Published on Thursday 29th of July 2010 08:44:41 AM
Posted by admin / Under Lacosamide
Schwarz Pharma has presented positive phase III data on lacosamide for the treatment of epilepsy.
Published on Thursday 29th of July 2010 08:44:41 AM
Do not forget to check the lastest products and auctions related to Lacosamide as well as our free videos and podcasts.
Spanish Armada: was defeated by the English, led by Sir Francis Drake (1588)
Share this!